Sale – Asian Citrus Holdings

Thursday, 25 November, 2010 16:56 Written by Paul 1 Comment

Another juicy little sale to report. This time it’s Asian Citrus Holdings (ACHL.L), our vitamin C packed, Chinese agricultural friends. And again, after make considerable gains in just over 12 months, it’s a slice off the top and we’ll retain a nice little holding for the good times ahead.

We bought into Asian Citrus back in October 2009 – here’s why – at 42.7 pence (well actually £4.27 but that was before a 10 for 1 stock split) and sold off exactly half our holding for 82 pence on 13th Novermber 2010.

In effect by the price doubling (we were 3 pence off but for the sake of the example) and selling half the holding, our current holding of 1,270 shares becomes a freebie. We’ve re-couped our initial investment and now we’re playing with their money. It’s a nice feeling.

Now to put that hard earned to work elsewhere. But more on that tomorrow.

Sale – Hutchison China Meditech

Monday, 22 November, 2010 15:35 Written by Paul 0 Comments

With a handful of shares on my must-have before Christmas list we chopped the top off a few of our more profitable holdings last week.

This is never easy to do, especially when you know there’s more to come. I’m a big fan of letting the good ones run (unfortunately I’ve been known to let the bad ones run too – see Cosalt – though I’m assured there’s good news to come…). But sometimes the potential and the pull of undervalued or oversold shares elsewhere is just too strong to ignore.

First of our performing shares to contribute to my special socialist model of portfolio management was Hutchison China Meditech (HCM.L). A wonderfully performing Chinese chunk of AIM that had leapt in price from £3.14 when we jumped in back in July of this year to £5.10 when we sold 220 of them off on 12th November.

Here’s the reasoning behind our original purchase and nowt has changed.

We’re still holding 300 of these bad boys and we’re still expecting big things.

Sale – Renesola

Tuesday, 09 November, 2010 11:57 Written by Paul 0 Comments

With last rites being performed on Renesola’s AIM listing before shifting their focus solely to their New York Stock Exchange listing, last Thursday 4th November we sold off our final tranche of 500 shares of our portfolio stalwart for 4.0150 pence a share and a total return of £2,007.50 before dealer costs.

We were averaged into Renesola at £1.12 a share so we took a 350% profit on Renesola this time round. Renesola has always been good to me over the years. Taking me up toward the giddy heights of £7 before I lost my nerve and smacked the sell key and letting me slip back in under a quid in that very same year. A favourite of the shorters so there’s always been plenty of banter on the BBs to boot. It’s been a wonderful ride.

Since we set out on the Investor Trader journey back in April 2009, Renesola has been our most heavily traded share, having bought in and out on nine occasions in the past 18 months. She was our financial muse. We’ll be sad to see her go.

As a token of our respect we’ve splashed a little cash back into the solar market with PV Crystalox Solar and of course there’s still a Chinese connection in our portfolio with Asian Citrus Holdings Limited and Hutchison China Meditech which are both performing admirably.

But nothing can ever replace that special blend of an alternative energy AIM share from China, in my mind at least. They’re not tears on my keyboard, just sweat from this spicy Szechuan chicken.

Sale – A Little More Renesola

Monday, 27 September, 2010 17:15 Written by Paul 0 Comments

So we pulled the trigger on Renesola and sold off 500 shares – half our holding – last Wednesday at a price of £3.5375 per share. The reasoning: well, besides SOLA.L pushing some two year highs, we’re working to a little bit of a deadline before Renesola dumps its AIM listing and takes all of its toys to New York.

So whilst it’s always nice to bank a triple-bagger (we are averaged into Renesola at £1.1227 per share) there’s still a sense of loss at what could have been. Put it this way. If Renesola’s move away from AIM wasn’t imminent, I wouldn’t have contemplated selling. Renesola’s chart of late is a ripper.

Now I know there are European based brokers out there willing and able to deal in New York and today markets are truly international, but to be honest, I’ve been happy in the past sticking primarily with UK based shares, albeit in this case with Chinese operations and a joint NYSE listing.

Adding a US component to my portfolio seems like an almost unnecessary risk. Close of markets in New York is past my bed time so there’s an element of not always being fully informed too. That’s my justification at any rate.

I’m still holding a further 500 shares and the price is still rising (it’s just touched £3.70 as I type) so I’ve still a got a few weeks left to decide whether to follow Renesola to the US.

Renesola and Another Dear John Letter

Tuesday, 21 September, 2010 19:23 Written by Paul 0 Comments

Readers of Investor Trader may remember my brief tryst with West China Cement which came to a premature end back in May of this year.

Sadly, growth saw them forget their roots, pull their AIM listing and try to make it in the big city. In this case, the big city being Hong Kong. And as it turns out, the big city has been quite kind witnessing gains in WCC in excess of 20% in the month since they headed east. I was willing to take that one on the chin. Let bygones be bygones and all that. Until……

Until yet another Dear John letter from my broker. This time it’s my beloved Renesola (another Chinese share) that are pulling their AIM listing and heading for another big city, well big apple to use the local parlance, New York. And no, my broker doesn’t trade on the NYSE. You seeing the theme here?

Anyway, to cut a long story short, I can either hunt down a broker that can trade across the pond or I can give up on my Renesola’s and keep my hard-earned in UK listed shares. I’ve got until early November to make my decision.

The spanner in the works is that Renesola is really flying at the minute making the timing all important.

I’ve been in and out of Renesola for years now and it’s the one share that I have consistently profited from. I’ve bought in at under a pound and I’ve sold at over six pounds with lots of buys and sells in between (and always for a profit I might add).

Currently Renesola sits just north of £3.50. Our portfolio holds 1,000 SOLA.L with an average purchase price of £1.12. If we sold today we’d be looking at a triple-bagger, not too bad by any standards, but it’s the forcing of my hand that I find hard to stomach.

So, what to do? Would you be looking at bailing out after a month like the one below?

Watch this space.

Posts Tagged ‘Investing in China’

Renesola and Another Dear John Letter

The Day in Numbers

Our Charismatic Benefactors

Our Friends at Kiva

Investor Trader Categories

Investor Trader Archives

Sites We Dig

Posts Tagged ‘Investing in China’

Sale – Asian Citrus Holdings

Sale – Hutchison China Meditech

Sale – Renesola

Sale – A Little More Renesola

Renesola and Another Dear John Letter

The Day in Numbers

Our Charismatic Benefactors

Our Friends at Kiva

What We Rant About

Investor Trader Categories

Investor Trader Archives

Sites We Dig